Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and anipamil

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with anipamil in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(anipamil)		Trials
(anipamil)		Recent Studies (post-2010) (anipamil)
9,1561875523130

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darius, H; Lefer, AM; Osborne, JA1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and anipamil

ArticleYear
In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.
    Research communications in chemical pathology and pharmacology, 1986, Volume: 52, Issue:2

    Topics: Adenosine Triphosphate; Animals; Arachidonic Acids; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Collagen; Male; Pharmaceutical Vehicles; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Propylamines; Rabbits

1986